Andrea Marshall

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Annie Young, Andrea Marshall, Jenny Thirlwall et al. · Journal of Clinical Oncology · 2018 · 1.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines

Andrea Marshall, Douglas G. Altman, Roger Holder et al. · BMC Medical Research Methodology · 2009 · 885 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Hugo Ford, Andrea Marshall, John Bridgewater et al. · The Lancet Oncology · 2013 · 604 citations · Full text

Public Health, Community Health, Communities Of Practice +14

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

Richard Gray, Daniel Rea, Kelly Handley et al. · Journal of Clinical Oncology · 2013 · 450 citations

Medicine, Oncology, Breast Oncology +11

Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study

Andrea Marshall, Douglas G. Altman, Patrick Royston et al. · BMC Medical Research Methodology · 2010 · 242 citations · Full text

Public Health, Biostatistics, Oncology +15